| # | Title | Journal | Year | Citations |
|---|
| 1 | Hearing aids for mild to moderate hearing loss in adults | The Cochrane Library | 2017 | 171 |
| 2 | An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation | Breast Cancer Research | 2017 | 161 |
| 3 | The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma | Clinical Nutrition | 2016 | 158 |
| 4 | Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity | Journal of Controlled Release | 2015 | 130 |
| 5 | Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival | Apoptosis: an International Journal on Programmed Cell Death | 2017 | 124 |
| 6 | Artificial intelligence in digital breast pathology: Techniques and applications | Breast | 2020 | 117 |
| 7 | Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer | Molecular Oncology | 2014 | 109 |
| 8 | Coping together with hearing loss: a qualitative meta-synthesis of the psychosocial experiences of people with hearing loss and their communication partners | International Journal of Audiology | 2017 | 107 |
| 9 | SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis | Lancet Oncology, The | 2016 | 105 |
| 10 | RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers | Cancer Research | 2017 | 93 |
| 11 | Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis | Breast Cancer Research and Treatment | 2016 | 81 |
| 12 | LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial | Journal of Cachexia, Sarcopenia and Muscle | 2018 | 80 |
| 13 | Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer | Molecular Oncology | 2015 | 75 |
| 14 | Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT–YB1–MDR1 Signaling Pathway | Cancer Research | 2016 | 75 |
| 15 | Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy | Molecular Oncology | 2015 | 72 |
| 16 | Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study | Archives of Disease in Childhood | 2017 | 72 |
| 17 | Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG) | Neuro-Oncology | 2021 | 68 |
| 18 | IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients | Cancer Immunology, Immunotherapy | 2018 | 67 |
| 19 | The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta‐analysis | Obesity Reviews | 2018 | 67 |
| 20 | Antenatal magnetic resonance imaging versus ultrasound for predicting neonatal macrosomia: a systematic review and meta‐analysis | BJOG: an International Journal of Obstetrics and Gynaecology | 2016 | 61 |
| 21 | Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer | Pathobiology | 2015 | 59 |
| 22 | Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ | Histopathology | 2017 | 58 |
| 23 | ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers | BBA Clinical | 2014 | 57 |
| 24 | The impact of self-efficacy, expectations, and readiness on hearing aid outcomes | International Journal of Audiology | 2016 | 57 |
| 25 | Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects | Neurogastroenterology and Motility | 2014 | 56 |
| 26 | DNA repair in cancer: emerging targets for personalized therapy | Cancer Management and Research | 2014 | 55 |
| 27 | Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study | Cancers | 2019 | 53 |
| 28 | Redox Proteins and Radiotherapy | Clinical Oncology | 2014 | 51 |
| 29 | Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy | Oncotarget | 2014 | 51 |
| 30 | Breast cancer intratumour heterogeneity: current status and clinical implications | Histopathology | 2018 | 50 |
| 31 | Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy | Oncotarget | 2014 | 47 |
| 32 | Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections | Breast Cancer Research and Treatment | 2017 | 44 |
| 33 | Calpain in Breast Cancer: Role in Disease Progression and Treatment Response | Pathobiology | 2015 | 43 |
| 34 | Advance care planning – a multi-centre cluster randomised clinical trial: the research protocol of the ACTION study | BMC Cancer | 2016 | 43 |
| 35 | Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines | Rheumatology | 2020 | 42 |
| 36 | Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19 | Radiology | 2022 | 41 |
| 37 | Diagnostic challenges in papillary lesions of the breast | Pathology | 2018 | 40 |
| 38 | What links ventilator driving pressure with survival in the acute respiratory distress syndrome? A computational study | Respiratory Research | 2019 | 38 |
| 39 | Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts | Neoplasia | 2014 | 37 |
| 40 | Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein | Breast Cancer Research and Treatment | 2016 | 37 |
| 41 | Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron | Alimentary Pharmacology and Therapeutics | 2019 | 37 |
| 42 | New Advances in Molecular Breast Cancer Pathology | Seminars in Cancer Biology | 2021 | 37 |
| 43 | Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy | Breast Cancer Research and Treatment | 2013 | 35 |
| 44 | Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response | British Journal of Cancer | 2015 | 35 |
| 45 | Heterozygous truncation mutations of the SMC1A gene cause a severe early onset epilepsy with cluster seizures in females: Detailed phenotyping of 10 new cases | Epilepsia | 2017 | 35 |
| 46 | Prognostic stratification of oestrogen receptor‐positive HER2‐negative lymph node‐negative class of breast cancer | Histopathology | 2017 | 30 |
| 47 | The role of adjuvant platinum‐based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery | Journal of Surgical Oncology | 2017 | 30 |
| 48 | Development and validation of a large, modular test meal with liquid and solid components for assessment of gastric motor and sensory function by non‐invasive imaging | Neurogastroenterology and Motility | 2016 | 29 |
| 49 | The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts | Breast Cancer Research and Treatment | 2016 | 29 |
| 50 | Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer | Breast Cancer Research and Treatment | 2014 | 27 |
